OCX
OncoCyte Corp
Price:  
2.39 
USD
Volume:  
13,478.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OCX WACC - Weighted Average Cost of Capital

The WACC of OncoCyte Corp (OCX) is 6.9%.

The Cost of Equity of OncoCyte Corp (OCX) is 9.70%.
The Cost of Debt of OncoCyte Corp (OCX) is 5.50%.

Range Selected
Cost of equity 8.20% - 11.20% 9.70%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 4.00% - 7.00% 5.50%
WACC 5.6% - 8.1% 6.9%
WACC

OCX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.94 1.12
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.20% 11.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 4.00% 7.00%
After-tax WACC 5.6% 8.1%
Selected WACC 6.9%